Anti-Bcl2 phosphorothioate G3139 clinical pharmacology: Plasma levels during continuous subcutaneous infusion by HPLC assay

Nucleosides and Nucleotides

Volumn 16, Issue 7-9, 1997, Pages 1683-1687

  Lebedev, A V ^a   Raynaud, F ^b   Dizik, M ^a   Beck, T ^a   Jaeger, J A ^a   Brown, B D ^a   Cunningham, D ^c   Webb, A ^c   McCampbell, E ^a   Riley, T ^a   Judson, I ^b   Woodle, M C ^a  

^a Genta Inc   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c Royal Marsden Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OBLIMERSEN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG SCREENING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PHASE 1 CLINICAL TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALIA;

EID: 9844240493     PISSN: 07328311     EISSN: None     Source Type: Journal    
DOI: 10.1080/07328319708006255     Document Type: Conference Paper

References (3)

1. Webb, A., Cunningham, D., Cotter, F., Hill, M., Clarke, P., di Stefano, F., Viner, C., Prendeville, J., Rahal, S., Dziewanowska, Z. (1996) Annals Oncology 7 (Supplement 3), Abstract 101.
2. Woodle, M. C., Raynaud, F. I., Dizik, M., Meyer, O., Huang, S.K., Jaeger, J. A., Brown, B. D., Judson, I. R., Papahadjopoulos, D. Nucleosides & Nucleotides (this issue).
3. Bourque, A. J., Cohen, A. S. (1994) J. Chromatogr. B, 662, 343-349.